Using Market|Exclusivity Incentives to Promote Pharmaceutical ...

Using market-exclusivity incentives to promote pharmaceutical ...

Using market-exclusivity incentives to promote pharmaceutical innovation.

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

Abstract. Several federal laws have encouraged the development of new drugs by offering longer market exclusivity. The author discusses unintended consequences ...

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation ... An analysis commissioned by Public Health Law Research has found that laws aimed at ...

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation. Author: Aaron S. Kesselheim, M.D., J.D., M.P.H.Author Info & Affiliations. Published ...

Using Market Exclusivity Incentives to Promote Pharmaceutical ...

The findings suggest that using market exclusivity incentives to promote pharmaceutical innovation has both benefits and substantial problems ...

The Drug Repurposing Ecosystem: Intellectual Property Incentives ...

The Article argues that there is a complex ecosystem in place and that additional or disruptive IP or market exclusivity incentives may harm as much as help in ...

[PDF] Using market-exclusivity incentives to promote pharmaceutical ...

It is suggested that future legislative efforts aimed at encouraging investment in drug R&D should be more precisely designed to avoid waste and misuse, ...

Data & Market Exclusivity As Incentives in Drug Development

Marketing exclusivity is a key incentive for drug developers. Exclusivity is designed to promote a balance between new drug innovation and ...

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

The findings suggest that using market exclusivity incentives to promote pharmaceutical innovation has both benefits and substantial problems for public health, ...

Pharmaceuticals, incremental innovation and market exclusivity

The policy tool of market exclusivity used to reward innovation has also become one of the main focal points in policy discussions to curb the soaring growth in ...

Reimagining Pharmaceutical Market Exclusivities - Value in Health

Results: An approach tying pharmaceutical market exclusivity ... Using market-exclusivity incentives to promote pharma- · ceutical innovation.

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

Publication Type: Article ; Journal Name: NEJM ; Full Citation: Kesselheim, A.S. "Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation." NEJM, ...

Six-Month Market Exclusivity Extensions To Promote Research Offer ...

Government-granted monopoly rights over pharmaceutical products are designed to reward innovation and then end, to provide incentives for ...

Patents and Exclusivity | FDA

With approaching patent expirations of several top selling prescription brand-name drugs, sponsors of innovator drug products and generic.

The Benefits From Giving Makers Of Conventional `Small Molecule ...

Pharmaceutical companies and generic drug manufacturers have long been at odds over “data exclusivity” regulations. These rules require a waiting period of up ...

Market Exclusivity and U.S. Prescription Drugs - Commonwealth Fund

Government-granted patents and periods of market and regulatory exclusivity provide manufacturers of brand-name pharmaceuticals with ...

Competitive Effects of Overlapping Drug Exclusivities

Does this overlap negate the orphan drug exclusivity incentive? In short, no, since the competitive impact of the two exclusivities is markedly ...

Marketing Exclusivity for Drug Developers: What is it & Different Types

Different than patents, Marketing Exclusivity is a key drug development incentive. Understand the types & timelines of different options for your program.

Using market-exclusivity incentives to promote pharmaceutical ...

Using market-exclusivity incentives to promote pharmaceutical innovation. ; All Authors: Authors. Kesselheim AS. ; Author Profiles: Persons. Aaron ...

Market exclusivity: orphan medicines

Market exclusivity is an orphan incentive awarded by the European Commission to a specific clinical indication with an orphan designation. Each indication with ...